SCP Vitalife Partners II LP, 10% Owner at Recro Pharma, Inc. (REPH), sold 77,620 shares at $9.04 ($689K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $689k REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.04 | 18,947 | $171K | 24.8% |
| 2 | $9.04 | 18,947 | $171K | 24.8% |
| 3 | $8.73 | 19,863 | $173K | 25.2% |
| 4 | $8.73 | 19,863 | $173K | 25.2% |
| Total | $8.88 avg | 77,620 | $689K | 100% |
| Filing → |
| REPH | SELL | 2018-01-08 | $42K | — | Filing → |
| REPH | SELL | 2018-01-02 | $338K | — | Filing → |
| REPH | SELL | 2017-12-28 | $206K | — | Filing → |